Journal of Bacteriology, September 1998, p. 4872-4878, Vol. 180, No. 18
0021-9193/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Escherichia coli tol-pal Mutants Form
Outer Membrane Vesicles
Alain
Bernadac,1
Marthe
Gavioli,1
Jean-Claude
Lazzaroni,2
Satish
Raina,3 and
Roland
Lloubès1,*
Laboratoire d'Ingénierie des
Systèmes Macromoléculaires, UPR 9027, CNRS, Institut de
Biologie Structurale et Microbiologie, 13402 Marseille Cedex
20,1 and
Laboratoire de Microbiologie et
Génétique Moléculaire, UMR 5534,
CNRS-Université Lyon 1, 69622 Villeurbanne
Cedex,2 France, and
Département
de Biochimie Médicale, Centre Médical Universitaire,
Geneva 4, Switzerland3
Received 9 March 1998/Accepted 7 July 1998
 |
ABSTRACT |
Mutations in the tol-pal genes induce pleiotropic
effects such as release of periplasmic proteins into the extracellular
medium and hypersensitivity to drugs and detergents. Other outer
membrane defective strains such as tolC, lpp,
and rfa mutations are also altered in their outer membrane
permeability. In this study, electron microscopy and Western blot
analyses were used to show that strains with mutations in each of the
tol-pal genes formed outer membrane vesicles after growth
in standard liquid or solid media. This phenotype was not observed in
tolC and rfaD cells in the same conditions. A
tolA deletion in three different Escherichia
coli strains was shown to lead to elevated amounts of vesicles.
These results, together with plasmid complementation experiments,
indicated that the formation of vesicles resulted from the defect of
any of the Tol-Pal proteins. The vesicles contained outer membrane trimeric porins correctly exposed at the cell surface. Pal outer membrane lipoprotein was also immunodetected in the vesicle fraction of
tol strains. The results are discussed in view of the role of the Tol-Pal transenvelope proteins in maintaining outer membrane integrity by contributing to target or integrate newly synthesized components of this structure.
 |
INTRODUCTION |
Different cell envelope proteins
have been proposed to link the inner and the outer membranes of
gram-negative bacteria. TonB inner membrane protein, involved in the
active transport of iron siderophores and vitamin B12,
interacts with outer membrane receptors (7, 34, 51). Export
systems in Escherichia coli contain membrane fusion proteins
which seem to bring a cytoplasmic membrane transporter (belonging to
either the ATP-binding cassette family, the major facilitator family,
or the multidrug resistance family) into contact with outer membrane
proteins such as TolC (16, 38). The TolA inner membrane
protein containing a long alpha-helical domain is also thought to cross
the periplasmic space (61). TolA belongs to the multiprotein
Tol-Pal complex. The topologies of the Tol-Pal proteins have been
previously characterized (25, 27, 30, 35, 44, 45, 57), and
these proteins have been shown to form two complexes in the cell
envelope. The TolA, TolQ, and TolR inner membrane proteins are
associated via their transmembrane segments (13, 33). The
TolB periplasmic protein interacts with the Pal outer membrane
lipoprotein (5). The function of these proteins is not
known, but a mutation in any of the tol-pal genes confers a
defect in outer membrane integrity resulting in hypersensitivity to
drugs and detergents and in leakage of periplasmic proteins to the
medium (32, 61). The tol-pal gene cluster encodes
two other proteins, Orf1 and Orf2, which are localized in the cytoplasm
and in the periplasm, respectively (58). The Tol-Pal system
is exploited for the entry of group A colicins and single-stranded DNA
phages, the TolB and TolR proteins being required only for entry of the
enzymatic E colicins and some pore-forming colicins such as colicin A
(1, 9, 12, 61). The TonB system, which is involved in active
transport, is used by group B pore-forming colicins (1, 11).
The ExbB, ExbD, and TonB inner membrane proteins show sequence
similarity with TolQ, TolR, and TolA proteins (17, 28).
However, outer membrane integrity defects observed in
tol-pal strains are not found in tonB cells.
Other cell envelope mutants have been reported to have outer membrane
defects. Mutations deleting the inner core region of the
lipopolysaccharide in rfa cells (23, 43, 50), the
major lipoprotein (56, 62), or blocking the maturation
process of porins (8) also induce hypersensitivity to
detergents and drugs. Cells devoided of the periplasmic peptidyl prolyl
isomerase, SurA, which seems to be involved in the folding of porins,
also exhibit altered membrane properties (43). A strain with
another outer membrane mutation, tolC, which confers reduced
OmpF synthesis, is hypersensitive to various antibacterial agents
(20, 42). Efflux mutations such as acrA or
acrE cells confer drug hypersusceptibility (37).
Unlike the outer membrane integrity mutants, AcrA and AcrE are inner
membrane lipoproteins involved in the AcrAB-TolC (19) or
AcrEF-outer membrane protein efflux pumps (38). However, only the tol-pal and lpp strains have been
reported to release periplasmic proteins into the medium. A more
pronounced outer membrane defect has been observed with lpp
ompA cells, which form vesicles under normal growth conditions
(52). Outer membrane vesicles were observed in
lpp strains overproducing periplasmic
-lactamase
(3). lpp strains, lacking the structural link
between the outer membrane and the peptidoglycan, also form vesicles
upon Mg2+ starvation (56, 62). In this study,
different strains affected in outer membrane integrity were analyzed by
electron microscopy (EM) and Western blotting. Each tol-pal
strain was found to form outer membrane vesicles containing native
outer membrane proteins. tol-pal cells were classified into
two groups based on the amount of vesicles formed.
 |
MATERIALS AND METHODS |
Strains and plasmids.
The strains and plasmids used in this
study are listed in Table 1. Strain
SC44tolA contains a Tn10 transposon which maps between min 16 and 17 of E. coli chromosome and the
tolA deletion of JC7782. P1 lysate of SC44tolA
cells was used to cotransduce the tolA deletion and the
tetracycline resistance in SR1458, giving strain LG10. This strain
transformed with a plasmid encoding TolA is sensitive to colicins A and
E3, indicating that Tn10 is inserted after the
tol-pal gene cluster.
Plasmid pARTolA was constructed by PCR amplification of the DNA
fragment corresponding to the N-terminal region of TolA (from residues
2 to 65, which contain the TolA inner membrane sequence). PCR was
carried out with pTPS306 as the template, using the following oligonucleotides (where the SphI restriction sites are
underlined, and N correspond to A, C, G, or T):
5'-NNNNNNGCATGC TGAGC TCAAAGGCAACCGAACAAAACGACAAGC-3' and 5'-CCTGGCTTTGCATGCGTTTGTACTGC-3'.
The PCR DNA fragment was digested with SphI and
purified on an acrylamide gel. Then, this 208-bp purified fragment was
inserted into the unique SphI site of pARTolAII-III, giving
pARTolA. Plasmid pARTolAII-III encodes an N-terminally
His6-tagged soluble TolA derivative corresponding to the
entire C-terminal periplasmic domain of TolA from residues 66 to 421 (15). Plasmid pARTolA was selected after transformation into
JC7782 (tolA) cells grown on LB agar containing 2%
deoxycholate and by DNA sequencing. Plasmid pAmpB was constructed from
pBR328 derivative containing the EcoRI-PvuII DNA
fragment of the tol gene cluster (4,645 bp) encoding Orf1,
TolQRAB. This plasmid was digested with NruI in order to
keep the tolB and bla genes and ori
and to remove the tet, orf1, and
tolQRA genes. Ampicillin-resistant plasmids were tested for
complementation of a tolB strain by using colicin
sensitivity tests, and expression of TolB was checked by
immunodetection.
EM analyses.
Negative staining of colonies grown overnight
on LB agar medium (containing 10 g of NaCl per liter) was
routinely done. Cells were suspended in Tris-buffered saline (10 mM
Tris-HCl [pH 8.0], 150 mM NaCl). Droplets were deposited onto freshly
ionized Formvar-carbon-coated grids for 1 min. Grids were negatively
stained with 1% aqueous uranyl acetate. Immunolabeling of LamB was
performed with cells grown on M9 minimum medium agar containing 0.4%
maltose as the sole carbon source (and 0.4% glycerol for the negative
control). Colonies, reisolated on the same medium, were suspended in
phosphate-buffered saline (PBS), and droplets were deposited onto
coated grids. The samples were fixed with 2% paraformaldehyde in PBS
(5 min) and incubated for 60 min with monoclonal antibody E302 (1/200
dilution). The samples were incubated with 10-nm-gold-conjugated
anti-mouse immunoglobulin G (Biocell) for 30 min. After extensive
washes in water, the grids were negatively stained with 0.5% aqueous uranyl acetate (1 min).
Ultrathin sections were obtained from cells grown overnight on disc
filters (Millipore type VC; 0.1-µm pore size) placed on LB agar
plates. Cell colonies were fixed with glutaraldehyde 2.5% in PBS (60 min), postfixed with 1% osmium tetroxide (60 min), dehydrated in
ethanol, and embedded in EMbed-812 (E.M.S.). Ultrathin sections were
stained with uranyl acetate and lead citrate.
RNase I periplasmic leakage and colicin tests.
Cells were
streaked on LB agar containing 1.5% RNA. After overnight incubation,
the addition of 10% trichloroacetic acid precipitated RNA with an
opaque zone, while a halo indicated that the RNA was degraded by
released periplasmic RNase I (18). Cells grown on LB medium
at the exponential growth phase were adsorbed on LB agar. Lawns were
spotted with 1-µl dilutions of purified colicins A and E1 and then
incubated overnight. Formation of a halo indicated sensitivity to
colicin. The incubation temperature was 37°C for all strains except
SR22 (30°C).
Immunodetection of vesicles.
Cells, grown either in LB
medium (containing 10 g of NaCl per liter) or in M9 minimal medium
supplemented with glycerol and amino acids, were collected at the early
exponential growth phase. Cells were pelleted by centrifugation at
3,000 × g for 5 min. The supernatants were either
centrifuged at 20,000 × g for 15 min to remove
remaining cells or filtered through 0.2-µm-pore-size filters (Gelman
HT). This supernatant was either analyzed directly or ultracentrifuged
at 250,000 × g for 45 min, yielding the vesicle pellet
and final supernatant. Supernatants were trichloroacetic acid
precipitated before analyses. For EM analyses, the vesicle pellets were
suspended in Tris-buffered saline and further centrifuged at
20,000 × g to remove vesicles not resuspended. Sodium
dodecyl sulfate-polyacrylamide gel electrophoresis and Western blotting were performed as previously described (14).
Antibodies.
Polyclonal antibodies raised against TolA
(anti-TolAIII or anti-TolAII-III, corresponding to the C-terminal
region or the whole periplasmic soluble form, respectively), TolB, Pal
proteins, porins (5, 13, 14), and TolC (60), and
anti-LamB monoclonal antibody E302 (29), have been
previously described. Anti-Lpp and anti
-lactamase polyclonal
antibodies were generous gifts of Danièle Cavard.
 |
RESULTS |
tolA and tolB-pal mutants release outer
membrane.
E. coli K-12 strains 1292, JC7782
(tolA), and JC7752 (tolB pal), all containing
plasmid pBR322 (4), were grown on LB medium to early
exponential growth phase. Cells and supernatants were analyzed for the
release of
-lactamase. It has been previously shown that in
tol-pal strains, periplasmic proteins such as
-lactamase, alkaline phosphatase, and RNase I leak into the extracellular medium
(32, 61). Coomassie blue-stained gels revealed that outer
membrane proteins OmpFC and OmpA were recovered in the supernatant as
major proteins without any detection of major cytoplasmic proteins such
as EF-Tu (not shown).
-Lactamase was also detected by Western blotting. The inner membrane TolA protein was immunodetected in JC7752
cells but not in the supernatant fraction. These results were obtained
by removing cells from culture supernatants either by low-speed
centrifugation (Fig. 1) or by filtration through 0.2-µm-pore-size
filters (not shown). When the supernatants were ultracentrifuged
(250,000 × g), only the
-lactamase was recovered in
the soluble fraction (Fig. 1). Because
immunodetection with an anti-LexA antibody gave negative results for
the supernatant fractions, as determined by Coomassie blue staining,
(not shown), we assumed that the cells were not lysed. We also observed
that the isogenic strain 1292 did not release periplasmic or outer membrane proteins. Furthermore, 1292 cells transformed with a multicopy
plasmid (either pBR322 [Fig. 1] or pUC9 [not shown]) and
overexpressing
-lactamase did not show outer membrane leakage. These
results suggest that tolA and tolB-pal cells
release outer membrane.

View larger version (51K):
[in this window]
[in a new window]
|
FIG. 1.
Immunoblot analyses of tolA (JC7782),
tolB pal (JC7752), and wild-type (wt) parent (1292) strains.
About 108 cells and the supernatant of 5 × 108 cells were analyzed after heat denaturation. S1 and S2
correspond to the supernatants resulting from centrifugation
(20,000 × g) and ultracentrifugation (250,000 × g), respectively. Three immunodetections were carried out
sequentially with antiporin (cross-reacting with OmpA),
anti- -lactamase ( -Lac), and anti-TolAIII antibodies.
|
|
Direct evidence of the release of outer membrane vesicles.
Supernatant fractions of JC8031 (tolRA), JC7782
(tolA), and LG10 (tolA) cells grown in LB medium
were ultracentrifuged and analyzed by Western blotting followed by
antiporin immunodetection. The outer membrane proteins found in the
supernatant (after centrifugation at 20,000 × g) were
recovered in the pellet obtained after ultracentrifugation (Fig.
2a). This pellet was resuspended and
adsorbed on a glow-discharged carbon-coated grid. After negative
staining and EM analyses, we observed that the samples contained small
vesicles with an average size of about 40 ± 20 nm (Fig. 2b). The
pellet obtained after centrifugation at 20,000 × g was
also analyzed and found to contain low amounts of larger vesicles (up
to 200 nm) and few lysed cells (not shown). To analyze the vesicle
envelope and cell localization of the vesicles, we used another
approach. Cell colonies grown on a disc filter placed on LB agar plates
were fixed in situ and resin embedded. Morphological analyses were
performed on ultrathin sections. Vesicles could clearly be seen on the
surface of cells without preferential pole or septum localization.
These sections demonstrated that the vesicles are enclosed by only one
membrane. Except for vesicles, tol cell envelopes do not
show any peculiar characteristic (Fig.
3).

View larger version (151K):
[in this window]
[in a new window]
|
FIG. 2.
(a) Immunodetection of OmpFC and OmpA in
tolRA (JC8031) cells, supernatants, and vesicles. Cells
(lane 1), supernatant (lane 2), and resuspended vesicle pellet of
ultracentrifugation (lane 3) of 5 × 108 cells are
shown. (b) Electron micrograph showing negative staining of the vesicle
suspension (same sample as analyzed in lane 3).
|
|
All tol-pal strains form vesicles.
Supernatant
fractions of tolA, tolB, tolQ,
tolR, and pal strains (either nonsense, missense,
or deletion mutants), grown in LB medium, were checked by Western
blotting with antiporin antibodies. Given the polar effect of
tolQ13 mutation on TolR and TolA expression (58),
we used strain TPS13(pTPS306) to check only the tolQ
mutation. In each mutant, we observed that the supernatant contained
outer membrane proteins as previously observed in tolRA,
tolA, or tolB pal cells, thus indicating that all
of the tol-pal strains had the same outer membrane defect
(Table 2). Complementation experiments were carried out to confirm that the effect was the result of tol-pal mutations. Cells were transformed with plasmids
carrying tol-pal genes able to complement the corresponding
chromosomal mutations, and supernatant fractions were immunodetected
with antiporin antibodies. We observed that the outer membrane defects of tol-pal strains were plasmids complemented for RNase I
leakage and for the absence of outer membrane porins in the
supernatants (Table 2). Plasmids pTPS304 (encoding TolR and TolQ) and
pQRA complement the tolQ13 mutation regardless of the level
of overexpression of TolA. However, it appeared that plasmid
complementations of TPS13, TPS300, and JC7782 were not total since
faint immunoreactions could be detected in the supernatants (Table 2).
EM analyses were carried out essentially by negative staining to
visualize directly a cell population without a centrifugation step,
which might introduce size exclusion. As a preliminary control, we
analyzed the supernatant fractions of tol cells grown on
solid or liquid culture medium by Western blotting. Porins were equally immunodetected in cell supernatants under these conditions (not shown).
EM observations revealed small vesicles. On the basis of multiple EM
observations, the tol-pal cells were classified into two
groups corresponding to the different amounts of vesicles (Table 2 and
Fig. 4). Numerous vesicles were recovered
from tolQ and tolR strains as well as from all
tolA strains except A5922. Low amounts of vesicles were
detected in tolB and pal strains. To confirm that
the amount of vesicles was not dependent on the isogenic strain 1292 background, the tolA deletion from JC7782 was transferred by
P1 transduction in strains C600 and MC4100 and further analyzed.
Numerous vesicles were observed in the supernatants of the three
tolA strains [JC7782, LG10, and
SC44tolA(pAX617)], indicating no dependence on the genetic
context for vesicle formation. The size of the vesicles was found to be
20 to 200 nm in all tol-pal mutants, without preferential
localization (Fig. 4). tol-pal strains complemented by
plasmids were also observed, and a good correlation of vesicles (from
cells growing on LB plates) with supernatant immunodetection (from
liquid culture) was found except for strains TPS13 and TPS300 (Table
2). Faint immunodetection could be correlated with low amounts of
vesicles in the case of complemented tolA strains, while in
complemented tolQ and tolR strains, no vesicles were observed. Immunodetection with anti-LexA antibody indicated that
after growth in liquid medium, few cells overexpressing inner membrane
Tol proteins, by multicopy plasmids, were lysed. However, EM results
showed few vesicles in the complemented tolA strain, indicating a partial restoration of outer membrane integrity. In
conclusion, tolA, tolQ, and tolR
strains were shown to form numerous vesicles, while tolB,
pal, and tolB-pal strains formed few vesicles.
The low level of vesicles detected in A5922 may be due to the
expression of a 400-residue TolA derivative which was immunodetected
(not shown).

View larger version (98K):
[in this window]
[in a new window]
|
FIG. 4.
Negative staining of tol cells and vesicles.
Electron micrographs are representative of the vesicle amounts: high
(a; JC7782 cells), low (b; JC7752 cells), and none (c; 1292 cells).
|
|
Outer membrane hypersensitive mutants and cell vesicles.
Some
mutants defective in outer membrane or periplasmic protein content
showed outer membrane alterations similar to those found in
tol strains, such as hypersensitivity to drugs and
detergents. Only the lpp (56) and the
tol-pal (18) cells were found to release
periplasmic proteins such as RNase I into the extracellular medium
(Table 2). We analyzed the supernatant fractions of SC44 (tolC), SR22 (htrM or rfaD), and
SR3205 (surA) mutants after growth in LB or M9 minimal
medium. No vesicle or outer membrane protein was detected in the
supernatant by EM experiments or by Western blot analyses (Table 2).
JE5506 and JC8963 (lpp ompA) strains were checked by the two
approaches, and only the latter strain was found to form high amounts
of vesicles. Interestingly, KS303 (lpp) cells were found to
form numerous vesicles, while in JE5505 (lpp) no or few
vesicles were detected regardless of the medium used (LB rich or M9
minimum medium with or without the addition of Mg2+).
Therefore, the two lpp strains (JE5505 and KS303) may differ by having accumulated a suppressor mutation(s) which renders JE5505 devoid of vesicles. All of the lpp strains used were checked
for the absence of Lpp by immunoblotting and periplasmic RNase I
leakage. We also verified that the lpp strains expressed the
TolQRAB-Pal proteins by testing for sensitivity to colicins A and E1
and by immunoblotting.
tol mutants and outer membrane proteins.
In
earlier studies, the only difference between tol and
isogenic strains with respect to the membrane defect was the diminution of the expression levels of the outer membrane proteins OmpF and LamB
(31). These variations were observed in cell pellets and with protein or operon fusions. Thus, it was of interest to compare the
relative amounts of porins in tol cells and in the vesicles. Cells were grown in LB medium devoid of NaCl (since low osmolarity induced OmpF expression). We found that OmpF was not recovered preferentially in the vesicles of tolA, tolB, and
tolRA strains. Similar results were obtained for LamB (not
shown), demonstrating low-level expression of OmpF and LamB in the
tol-pal mutants. Thus, the lower amounts of OmpF and LamB
might be an indirect effect relative to osmoregulation (9).
High amounts of vesicles were also detected when tolA cells
were grown at a low temperature (Table 2) which was previously shown to
induce capsular polysaccharide synthesis (10), indicating
that mucoidy does not prevent the formation of vesicles in
tolA cells.
The oligomeric state of the porins recovered in the vesicle fractions
of tol cells was checked by Western blot analyses using samples heat denatured or not. Monomeric porins OmpF and OmpC could be
immunodetected only at 96°C. OmpA was immunodetected at its native or
denatured electrophoretic mobility, as demonstrated by sample heating
at 37 or 96°C, respectively (not shown). The exposure of LamB porin
at the surface of the vesicles was investigated by EM immunodetection
using monoclonal antibody E302, raised against the external loop L9 of
LamB (29). LG10 cells, grown on minimal medium plates, were
adsorbed on grids and immunogold labeled. Gold particles on the surface
of cells and vesicles were observed only after maltose induction (not
shown). These results indicated correct exposure of the LamB L9 loop
and correct assembly of trimeric porins present in the vesicles of the
tol strains. In addition to LamB, OmpFC, and OmpA, TolC was
immunodetected in the outer membrane vesicles (not shown). Using an
anti-TolB-Pal antibody, we detected the Pal lipoprotein in the vesicle
fraction of tol strains and found TolB in the extracellular
medium and in the vesicle pellets (Fig.
5). Periplasmic TolB is then released,
and its presence in the vesicles probably reflects its interaction with
Pal.

View larger version (70K):
[in this window]
[in a new window]
|
FIG. 5.
Immunodetection of TolB and Pal in the supernatants and
vesicle fractions of tolQ (TPS13) and tolR
(TPS300) cells. Cells, vesicles (Ves), cell supernatant (S1), and
ultracentrifuged supernatant (S2) were loaded in the same amounts as
for Fig. 1 and subjected to immunodetection with anti-TolB-Pal
antibodies.
|
|
 |
DISCUSSION |
In this work, we showed that tol-pal strains form
vesicles containing outer membrane proteins such as trimeric porins.
The EM assays facilitate observations of cells by virtue of their rapid
and simple approach without any size exclusion. tol-pal or
lpp cells from single bacteria were appeared different from other cells. However, some vesicles could be observed in nearly all of
the E. coli cells that we analyzed. The level of vesicle formation was found to be high in tolA, tolQ, and
tolR strains and low in tolB and pal
strains. Thus, a major outer membrane defect should be attributed to
alteration of the TolAQR complex rather than the TolB-Pal complex.
Aside from the EM classification data obtained with adsorbed material,
we have not yet precisely quantified the differences between
tolABQR and pal cells. However, densitometry
scannings of blue-stained outer membrane porins of tol-pal
cell membranes and supernatant filtrates indicated that between 10 and
20% of porins were found in vesicles.
Recent results indicated that the TolB-Pal complex interacted in vivo
with the Lpp and OmpA proteins and that the expression of Pal was
increased in an lpp ompA strain (9). Together
with our data, these results suggest that the Tol-Pal proteins may be
involved in a structural cell envelope network. Hence, the TolB-Pal
outer membrane complex interacted with the peptidoglycan and might be
linked to the TolAQR inner membrane complex through direct or indirect
interaction. Then, a defect in any of the Tol protein might disrupt the
stoichiometry of the Tol-Pal transenvelope complex, inducing vesicle
formation. However, no experimental evidence for the interaction
between the two complexes TolAQR and TolB-Pal-peptidoglycan has been
demonstrated. The Tol-Pal complex may also be involved in the
integration of newly synthesized outer membrane components. Indeed,
these two potential roles are not incompatible. Because porins were
found to interact in vitro with TolA and TolB (14, 49), the
absence of a functional Tol-Pal complex of definite stoichiometry
(22) would lead to the release rather than correct
integration of outer membrane components. The induction of cell
hypersensitivity and colicin tolerance had been previously shown for
wild-type cells overexpressing periplasmic TolA derivatives
(36) or periplasmic N-terminal domains of group A colicins
(6). These results indicated that the Tol-Pal complex can be
destabilized even when present in the cell envelope. Preliminary experiments revealed that vesicle formation was stopped upon carbon starvation of exponentially growing tolA cells, indicating
that this process was dependent on cell growth. All of these results suggest a role of the Tol-Pal proteins in assuming a transient link
between the two membranes and the peptidoglycan. Further analyses of
vesicles and outer membrane fractions after pulse-chase labeling
experiments will indicate if the Tol-Pal proteins contribute in the
dynamic integration of outer membrane components.
An interesting aspect concerns the relationship between (i)
hypersensitivity to drugs and detergents and (ii) vesicle detection. We
observed that tolC, surA, and rfa
cells did not form vesicles. Efficient release of outer membrane in
rfa cells treated with EDTA has been demonstrated
(39). In accord with this observation, in the absence of
EDTA, no vesicles were detected in the rfaD strain.
lpp strains were previously shown to form vesicles under low
concentrations of Mg2+ (21, 52, 56) or
overexpression of periplasmic proteins (3). In the two
lpp strains used, we observed that KS303 formed numerous
vesicles whereas JE5505 did not. However, JE5505ompA (lpp ompA double mutant) was the strain which formed the
greatest number of vesicles, while ompA strain JC8931 had no
obvious outer membrane defect. All of these lpp strains
contain the Tol-Pal proteins. Hence, it appears that an independent
genetic event may differentiate the two lpp strains. As for
the lpp strains, we suspected that vesicles recovered in the
tol-pal strains may be a consequence of the absence of Pal
(or its association with the peptidoglycan). Because the pal
mutants formed lower amounts of vesicles compared to the
tolAQR strains, this possibility did not seem likely.
Furthermore, we observed that each of the tolABQR mutations
did not prevent the localization of Pal in the vesicle fraction, which
probably reflects its correct outer membrane localization. Thus,
sorting and transport of Pal to the outer membrane, driven by the
periplasmic LolA (40) and outer membrane LolB
(41) proteins, is not prevented by the periplasmic leaky
phenotype of tol cells.
The last point of relevance is the detection in other gram-negative
bacteria such as Pseudomonas aeruginosa (26) or
Neisseria gonorrhoeae (46) of outer membrane
vesicles which were suspected to interfere with bacterial pathogenesis.
As homologs of the Tol-Pal proteins have been found in the genomes of
all gram-negative bacteria sequenced so far, a better understanding of
their regulation and involvement in vesicle formation is of interest.
 |
ACKNOWLEDGMENTS |
We are grateful to Cécile Wandersman for the
tolC and tolA tolC strains and the TolC plasmid
and antiserum, Alain Charbit and Danièle Cavard for antibodies,
Dominique Missiakas for genetic techniques, Emmanuelle Bouveret and
Hélène Bénédetti for careful reading of the
manuscript, Alain Rigal for figures, and Claude Lazdunski for
encouragements.
This work was supported by the CNRS.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Laboratoire
d'Ingénierie des Systèmes Macromoléculaires, UPR
9027, CNRS, Institut de Biologie Structurale et Microbiologie 13402 Marseille Cedex 20, France. Phone: 33-4-91-76-03-59. Fax:
33-4-91-71-21-24. E-mail: lloubes{at}ibsm.cnrs-mrs.fr.
 |
REFERENCES |
| 1.
|
Bénédetti, H., and V. Géli.
1996.
Colicin transport, channel formation and inhibition, p. 665-691.
In
W. N. Konings, H. R. Kaback, and J. S. Lolkema (ed.), Handbook of biological physics, vol. 2. Elsevier Science Publishers, Amsterdam, The Netherlands.
|
| 2.
|
Bénédetti, H.,
C. Lazdunski, and R. Lloubès.
1991.
Protein import into E. coli: colicins A and E1 interact with a component of their translocation system.
EMBO J.
10:1989-1995[Medline].
|
| 3.
|
Bernadac, A.,
J. M. Bolla,
M. Inouye, and J. M. Pagès.
1987.
Precise localization of an overproduced periplasmic protein in E. coli: use of a double immuno-gold labelling.
Biol. Cell
61:141-147[Medline].
|
| 4.
|
Bolivar, F.,
R. Rodriguez,
P. Greene,
M. Betlach,
H. Heyneker, and H. Boyer.
1977.
Construction and characterization of new cloning vehicles.
Gene
2:95-113[Medline].
|
| 5.
|
Bouveret, E.,
R. Derouiche,
A. Rigal,
R. Lloubès,
C. Lazdunski, and H. Bénédetti.
1995.
Peptidoglycan-associated lipoprotein-TolB interaction.
J. Biol. Chem.
270:11071-11077[Abstract/Free Full Text].
|
| 6.
|
Bouveret, E.,
A. Rigal,
C. Lazdunski, and H. Bénédetti.
1998.
Distinct regions of the colicin A translocation domain are involved in the interaction with TolA and TolB proteins upon import into E. coli.
Mol. Microbiol.
27:143-157[Medline].
|
| 7.
|
Braun, V.
1995.
Energy-coupled transport and signal transduction through the Gram-negative outer membrane via TonB-ExbB-ExbD-dependent receptors proteins.
FEMS Microbiol. Rev.
16:295-307[Medline].
|
| 8.
|
Carlson, J., and T. Silhavy.
1993.
Signal sequence processing is required for the assembly of LamB trimers in the outer membrane of Escherichia coli.
J. Bacteriol.
175:3327-3334[Abstract/Free Full Text].
|
| 9.
|
Clavel, T.,
P. Germon,
A. Vianney,
R. Portalier, and J. C. Lazzaroni.
1998.
TolB protein of Escherichia coli K12 interacts with the outer membrane peptidoglycan-associated proteins Pal, Lpp and OmpA.
Mol. Microbiol.
29:359-367[Medline].
|
| 10.
|
Clavel, T.,
J. C. Lazzaroni,
A. Vianney, and R. Portalier.
1996.
Expression of the tolQRA genes of E. coli K-12 is controlled by the RcsC sensor protein involved in capsule synthesis.
Mol. Microbiol.
19:19-25[Medline].
|
| 11.
|
Davies, J., and P. Reeves.
1975.
Genetics of resistance to colicins in Escherichia coli K-12: cross-resistance among colicins of group B.
J. Bacteriol.
123:96-101[Abstract/Free Full Text].
|
| 12.
|
Davies, J., and P. Reeves.
1975.
Genetics of resistance to colicins in Escherichia coli K-12: cross-resistance among colicins of group A.
J. Bacteriol.
123:102-117[Abstract/Free Full Text].
|
| 13.
|
Derouiche, R.,
H. Bénédetti,
J. C. Lazzaroni,
C. Lazdunski, and R. Lloubès.
1995.
Protein complex within E. coli inner membrane.
J. Biol. Chem.
270:11078-11084[Abstract/Free Full Text].
|
| 14.
|
Derouiche, R.,
M. Gavioli,
H. Bénédetti,
A. Prilipov,
C. Lazdunski, and R. Lloubès.
1997.
TolA central domain interacts with E. coli porins.
EMBO J.
15:6408-6415.
|
| 15.
|
Derouiche, R.,
G. Zeder-Lutz,
H. Bénédetti,
M. Gavioli,
A. Rigal,
C. Lazdunski, and R. Lloubès.
1997.
Binding of colicins A and E1 to purified TolA domains.
Microbiology
143:3185-3192.
|
| 16.
|
Dinh, T.,
I. Paulsen, and M. Saier.
1994.
A family of extracytoplasmic protein that allow transport of large molecules across the outer membrane of gram-negative bacteria.
J. Bacteriol.
176:3825-3831[Abstract/Free Full Text].
|
| 17.
|
Eick-Helmerich, K., and V. Braun.
1989.
Import of biopolymers into Escherichia coli: nucleotide sequences of exbB and exbD genes are homologous to those of the tolQ and tolR genes, respectively.
J. Bacteriol.
171:5117-5127[Abstract/Free Full Text].
|
| 18.
|
Fognini-Lefebvre, N.,
J. C. Lazzaroni, and R. Portalier.
1987.
tolA, tolB and excC, three cistrons involved in the control of pleiotropic release of periplasmic proteins by E. coli K12.
Mol. Gen. Genet.
209:391-395[Medline].
|
| 19.
|
Fralick, J.
1996.
Evidence that TolC is required for functioning of the Mar/AcrAB efflux pump of Escherichia coli.
J. Bacteriol.
178:5803-5805[Abstract/Free Full Text].
|
| 20.
|
Fralick, J., and L. Burns-Keliher.
1994.
Additive effect of tolC and rfA mutations on the hydrophobic barrier of the outer membrane of Escherichia coli K-12.
J. Bacteriol.
176:6404-6406[Abstract/Free Full Text].
|
| 21.
|
Fung, T.,
T. MacLister, and L. Rothfield.
1978.
Role of murein lipoprotein in morphogenesis of the bacterial division septum: phenotype similarity of lkyD and lpo mutants.
J. Bacteriol.
133:1467-1471[Abstract/Free Full Text].
|
| 22.
|
Guihard, G.,
P. Boulanger,
H. Bénédetti,
R. Lloubès,
M. Besnard, and L. Letellier.
1994.
Colicin A and the Tol proteins involved in its translocation are preferentially located in the contact sites between the inner and outer membranes of E. coli cells.
J. Biol. Chem.
269:5874-5880[Abstract/Free Full Text].
|
| 23.
|
Hancock, R.
1997.
The bacterial outer membrane as a drug barrier.
Trends Microbiol.
7:37-42.
|
| 24.
|
Hiraga, S.,
H. Niki,
T. Ogura,
C. Ichinose,
H. Mori,
B. Ezaki, and A. Jaffé.
1989.
Chromosome partitioning in Escherichia coli novel mutants producing anucleate cells.
J. Bacteriol.
171:1496-1505[Abstract/Free Full Text].
|
| 25.
|
Isnard, M.,
A. Rigal,
J. C. Lazzaroni,
C. Lazdunski, and R. Lloubès.
1994.
Maturation and localization of the TolB protein required for colicin import.
J. Bacteriol.
176:6392-6396[Abstract/Free Full Text].
|
| 26.
|
Kadurugamuwa, J., and T. Beveridge.
1995.
Virulence factors released from Pseudomonas aeruginosa in association with membrane vesicles during normal growth and exposure to gentamicin: a novel mechanism of enzyme secretion.
J. Bacteriol.
177:3998-4008[Abstract/Free Full Text].
|
| 27.
|
Kampfenkel, K., and V. Braun.
1993.
Membrane topologies of the TolQ and TolR proteins of Escherichia coli: inactivation of TolQ by a missense mutation in the proposed first transmembrane segment.
J. Bacteriol.
175:4485-4491[Abstract/Free Full Text].
|
| 28.
|
Karlsson, M.,
K. Hannavy, and C. Higgins.
1993.
A sequence-specific function for the N-terminal signal-like sequence of the TonB protein.
Mol. Microbiol.
8:379-388[Medline].
|
| 29.
|
Klebba, P. E.,
S. M. C. Newton,
A. Charbit,
V. Michel,
D. Perrin, and M. Hofnung.
1997.
Further genetic analysis of the C-terminal external loop region in E. coli maltoporin.
Res. Microbiol.
148:375-387[Medline].
|
| 30.
|
Lazzaroni, J. C., and R. Portalier.
1992.
The excC gene of E. coli K-12 required for cell envelope integrity encodes the peptidoglycan-associated lipoprotein (PAL).
Mol. Microbiol.
6:735-742[Medline].
|
| 31.
|
Lazzaroni, J. C.,
N. Fognini-Lefebvre, and R. Portalier.
1986.
Effects of IkyB mutations on the expression of ompF, ompC and lamB porin structural genes in E. coli K-12.
FEMS Microbiol. Lett.
33:235-239.
|
| 32.
|
Lazzaroni, J. C.,
N. Fognini-Lefebvre, and R. Portalier.
1989.
Cloning of excC and excD genes involved in the release of periplasmic proteins by E. coli K-12.
Mol. Gen. Genet.
218:460-464[Medline].
|
| 33.
|
Lazzaroni, J. C.,
A. Vianney,
J. L. Popot,
H. Benedetti,
F. Samatey,
C. Lazdunski,
R. Portalier, and V. Geli.
1995.
Transmembrane alpha-helix interactions are required for the functional assembly of the E. coli Tol complex.
J. Mol. Biol.
246:1-7[Medline].
|
| 34.
|
Letain, T., and K. Postle.
1997.
TonB protein appears to transduce energy by shuttling between the cytoplasmic membrane and the outer membrane in E. coli.
Mol. Microbiol.
24:271-283[Medline].
|
| 35.
|
Levengood, S.,
W. Beyer, and R. Webster.
1991.
TolA: a membrane protein involved in colicin uptake contains an extended helical region.
Proc. Natl. Acad. Sci. USA
88:5939-5943[Abstract/Free Full Text].
|
| 36.
|
Levengood-Freyermuth, S.,
E. Click, and R. Webster.
1993.
Role of the carboxy-terminal domain of TolA in protein import and integrity of the outer membrane.
J. Bacteriol.
175:222-228[Abstract/Free Full Text].
|
| 37.
|
Ma, D.,
D. Cook,
M. Alberti,
N. Pon,
H. Nikaido, and J. Hearst.
1993.
Molecular cloning and characterization of acrA and acrE genes of Escherichia coli.
J. Bacteriol.
175:6299-6313[Abstract/Free Full Text].
|
| 38.
|
Ma, D.,
D. Cook,
J. Hearst, and H. Nikaido.
1994.
Efflux pumps and drug resistance in Gram-negative bacteria.
Trends Microbiol.
2:489-493[Medline].
|
| 39.
|
Marvin, H.,
M. Ter Beest, and B. Witholt.
1989.
Release of outer membrane fragments from wild-type Escherichia coli and from several E. coli lipopolysaccharide mutants by EDTA and heat shock treatments.
J. Bacteriol.
171:5262-5267[Abstract/Free Full Text].
|
| 40.
|
Matsuyama, S.,
T. Tajima, and H. Tokuda.
1995.
A novel periplasmic carrier protein involved in the sorting and transport of E. coli lipoproteins destined for the outer membrane.
EMBO J.
14:3365-3372[Medline].
|
| 41.
|
Matsuyama, S.,
N. Yokota, and H. Tokuda.
1997.
A novel outer membrane lipoprotein, LolB, involved in the LolA (p20)-dependent localization of lipoproteins to the outer membrane of E. coli.
EMBO J.
16:6947-6955[Medline].
|
| 42.
|
Misra, R., and P. Reeves.
1987.
Role of micF in the tolC-mediated regulation of OmpF, a major outer membrane protein of Escherichia coli K-12.
J. Bacteriol.
169:4722-4730[Abstract/Free Full Text].
|
| 43.
|
Missiakas, D.,
J. M. Betton, and S. Raina.
1996.
New components of protein folding in extracytoplasmic compartments of E. coli SurA, FkpA, and Skp/OmpH.
Mol. Microbiol.
21:871-884[Medline].
|
| 44.
|
Mizuno, T.
1979.
A novel peptidoglycan-associated lipoprotein found in the cell envelopes of Pseudomonas aeruginosa and Escherichia coli.
J. Biochem.
86:991-1000[Abstract/Free Full Text].
|
| 45.
|
Müller, M. M.,
A. Vianney,
J. C. Lazzaroni,
R. E. Webster, and R. Portalier.
1993.
Membrane topology of the Escherichia coli TolR protein required for cell envelope integrity.
J. Bacteriol.
175:6059-6061[Abstract/Free Full Text].
|
| 46.
|
Pettit, R., and R. Judd.
1992.
Characterization of naturally elaborated blebs from serum-susceptible and serum-resistant strains of Neisseria gonorrhoeae.
Mol. Microbiol.
6:723-728[Medline].
|
| 47.
|
Raina, S., and C. Georgopoulos.
1991.
The htrM gene, whose product is essential for E. coli viability only at elevated temperatures, is identical to the rfaD gene.
Nucleic Acids Res.
19:3811-3819[Abstract/Free Full Text].
|
| 48.
|
Raina, S.,
D. Missiakas, and C. Georgopoulos.
1995.
The rpoE gene encoding the E heat shock sigma factor of E. coli.
EMBO J.
14:1043-1055[Medline].
|
| 49.
|
Rigal, A.,
E. Bouveret,
R. Lloubès,
C. Lazdunski, and H. Bénédetti.
1997.
The TolB protein interacts with the porins of Escherichia coli.
J. Bacteriol.
179:7274-7279[Abstract/Free Full Text].
|
| 50.
|
Schnaitman, C., and J. Klena.
1993.
Genetic of lipopolysaccharide biosynthesis in enteric bacteria.
Microbiol. Rev.
57:655-682[Abstract/Free Full Text].
|
| 51.
|
Skare, J.,
B. Ahmer,
C. Seachord,
R. Darveau, and K. Postle.
1993.
Energy transduction between membranes. TonB, a cytoplasmic membrane protein, can be chemically cross-linked in vitro to the outer membrane receptor FepA.
J. Biol. Chem.
268:16302-16308[Abstract/Free Full Text].
|
| 52.
|
Sonntag, I.,
H. Schwarz,
Y. Hirota, and U. Henning.
1978.
Cell envelope and shape of Escherichia coli: multiple mutants missing the outer membrane lipoprotein and other major outer membrane proteins.
J. Bacteriol.
136:280-285[Abstract/Free Full Text].
|
| 53.
|
Strauch, K., and J. Beckwith.
1988.
An E. coli mutation preventing degradation of abnormal periplasmic proteins.
Proc. Natl. Acad. Sci. USA
85:1576-1580[Abstract/Free Full Text].
|
| 54.
|
Sun, T., and R. Webster.
1986.
fii, a bacterial locus required for filamentous phage infection and its relation to colicin-tolerant tolA and tolB.
J. Bacteriol.
165:107-115[Abstract/Free Full Text].
|
| 55.
|
Sun, T., and R. Webster.
1987.
Nucleotide sequence of a gene cluster involved in entry of E colicins and single-stranded DNA of infecting filamentous bacteriophages into Escherichia coli.
J. Bacteriol.
169:2667-2674[Abstract/Free Full Text].
|
| 56.
|
Susuki, H.,
Y. Nishimura,
S. Yasuda,
A. Nishimura,
M. Yamada, and Y. Hirota.
1978.
Murein-lipoprotein of E. coli: a protein involved in the stabilization of bacterial envelope.
Mol. Gen. Genet.
167:1-9[Medline].
|
| 57.
|
Vianney, A.,
T. Lewin,
W. Bayer,
J. C. Lazzaroni,
R. Portalier, and R. Webster.
1994.
Membrane topology and mutational analysis of the TolQ protein of Escherichia coli required for the uptake of macromolecules and cell envelope integrity.
J. Bacteriol.
176:822-829[Abstract/Free Full Text].
|
| 58.
|
Vianney, A.,
M. Müller,
T. Clavel,
J. C. Lazzaroni,
R. Portalier, and R. Webster.
1996.
Characterization of the tol-pal region of Escherichia coli K-12: translational control of tolR expression by TolQ and identification of a new open reading frame downstream of pal encoding a periplasmic protein.
J. Bacteriol.
178:4031-4038[Abstract/Free Full Text].
|
| 59.
|
Wandersmann, C., and P. Delepelaire.
1990.
TolC, an E. coli outer membrane protein required for haemolysin secretion.
Proc. Natl. Acad. Sci. USA
87:4776-4780[Abstract/Free Full Text].
|
| 60.
|
Wandersmann, C., and S. Létoffé.
1993.
Involvement of lipopolysaccharide in the secretion of Escherichia coli -haemolysin and Erwinia chrysanthemi proteases.
Mol. Microbiol.
7:141-150[Medline].
|
| 61.
|
Webster, R.
1991.
The tol gene products and the import of macromolecules into E. coli.
Mol. Microbiol.
5:1005-1011[Medline].
|
| 62.
|
Yem, W., and H. Wu.
1978.
Physiological characterization of an Escherichia coli mutant altered in the structure of murein lipoprotein.
J. Bacteriol.
133:1419-1426[Abstract/Free Full Text].
|
Journal of Bacteriology, September 1998, p. 4872-4878, Vol. 180, No. 18
0021-9193/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.